| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |